DexCom Aktie
88,34USD | 0,52USD | 0,59% |
WKN: A0D9T1 / ISIN: US2521311074
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 6 400 | 6 300 | 7 600 | 9 600 | 10 300 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,30 | 0,39 | 0,38 | 0,38 | 0,39 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 3 425 | 3 684 | 3 669 | 4 426 | 4 301 |
Summe Anlagevermögen | 958 | 1 179 | 1 723 | 1 839 | 2 183 |
Summe Aktiva | 4 383 | 4 864 | 5 392 | 6 265 | 6 485 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 2 556 | 2 612 | 3 260 | 4 196 | 4 382 |
Summe Eigenkapital | 1 827 | 2 252 | 2 132 | 2 069 | 2 103 |
Summe Passiva | 4 383 | 4 864 | 5 392 | 6 265 | 6 485 |
Adresse
6340 Sequence Drive, 92121 San Diego | |
Telefon | +1 (858) 200-0200 |
Internet | http://www.dexcom.com |
Management
Barry J. Regan
Executive Vice President-Global Operations |
Bridgette P. Heller
Independent Director |
Donald M. Abbey
Executive VP-IT Quality & Regulatory Affairs |
Eric J. Topol
Independent Director |
Girish Naganathan
Chief Technology Officer & Executive VP |
Jacob S. Leach
Chief Operating Officer & Executive Vice President |
Jereme M Sylvain
Chief Financial Officer & Executive Vice President |
Karen M. Dahut
Independent Director |
Kevin Ronald Sayer
Chairman, President & Chief Executive Officer |
Kyle J. Malady
Independent Director |
Mark G. Foletta
Lead Independent Director |
Matt V. Dolan
Executive VP-Strategy & Corporate Development |
Michael Jon Brown
Chief Legal Officer & Executive Vice President |
Nicholas Augustinos
Independent Director |
Paul R. Flynn
Executive Vice President-Global Revenue |
Richard Alexander Collins
Independent Director |
Rimma Driscoll
Independent Director |
Sadie M Stern
Chief Human Resources Officer & Executive VP |
Sean Christensen
Vice President-Finance & Investor Relations |
Shelly R. Selvaraj
Chief Information Officer & Senior Vice President |
Steven R. Altman
Independent Director |
Steven Robert Pacelli
Executive VP & Managing Director-Dexcom Ventures |
Teri L. Lawver
Chief Commercial Officer & Executive VP |